TherapeuticsMD, Inc. — Director's Dealing 2021

May 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2021-05-14

Reporting Person: Thompson Tommy G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-14	Common Stock	P	5000	$1.06	Acquired	704600	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1001	Indirect
Common Stock	3555	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions with prices ranging from $1.055 to $1.06 for an average weighted sale price of $1.06. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2: The reported securities are owned by Thompson Family Investments, LLC, an entity solely owned by Thompson Family Holdings, LLC, an entity solely owned by Mr. Thompson.

F3: The reported securities are owned by Thompson Family Holdings, LLC, an entity solely owned by Mr. Thompson.